Hepatorenal syndrome;Das hepatorenale syndrom

Intensivmedizin und Notfallmedizin

Volumn 35, Issue 6, 1998, Pages 390-400

  Wrenger, E ^a   Brunkhorst, R ^b   Malfertheiner, P ^a   Neumann, K H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Diagnosis; Differential diagnosis; Hepatorenal syndrome; Pathophysiology; Treatment

Indexed keywords

ENDOTHELIN; NATRIURETIC FACTOR; NITRIC OXIDE; PROSTANOID; VASOPRESSIN;

ADRENERGIC SYSTEM; HEPATORENAL SYNDROME; HUMAN; KIDNEY CORTEX; KIDNEY FAILURE; LIVER DISEASE; LIVER TRANSPLANTATION; MORTALITY; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASOCONSTRICTION; VASODILATATION;

EID: 0031688752     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050165     Document Type: Review

References (96)

1. Abraham WT, Lauwaars ME, Kim JK, Pena RL. Schrier RW (1995) Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis. Hepatology 22: 737-743
2. Ames RP. Borkowski AJ, Sicinski AM. Laragh JM (1965) Prolonged infusion of angiotensin II and norepinephrine on blood pressure, electrolyte balance and aldosterone and cortisol secretion in normal man and cirrhosis with ascites. J Clin Invest 44: 1171-1186
3. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H. Schölmerich J (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23: 164-176
4. Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H (1994) Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 19: 129-132
5. Bacq Y, Gaudin C, Hadengue A, Roulot D, Braillon A, Moreau R, Lebrec D (1991) Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology 14: 483-487
6. Banares R, Casado M, Rodriguez-Laiz JM, Camunez F, Matilla A, Echenagusia A, Simo G, Piqueras B, Clemente G, Cos E (1998) Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 93: 75-79
7. Barnado DE, Baldus WP, Maher FT (1970) Effects of dopamine on renal function in patients with cirrhosis. Gastroenterology 58: 524-531
8. Bennett WM, Keeffe E, Melnyk C, Mahler D, Rosch J, Porter GA (1975) Response to dopamine hydrochloride in the hepatorenal syndrome. Arch Intern Med 135: 964-971
9. Bichet D, Szatalowicz V, Chaimovitz C, Schrier RW (1982) Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med 96: 413-417
10. Bichet DG, Van Putten VJ, Schrier RW (1982) Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 307: 1552-1557
11. Bomzon A, Blendis LM (1994) The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 20: 1343-1350
12. Brabant G, Jüppner H, Kirschner M, Böker K, Schmidt FW, Hesch RD (1986) Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites. Klin Wochenschr 64 Suppl 6: 108-111
13. Brensina KA, Textor J, Strunk H, Klehr HU, Schild H, Sauerbruch T (1997) Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 349: 697-698
14. Brunkhorst R, Wrenger E, Kühn K, Schmidt FW, Koch K (1989) Effekte einer Captopriltherapie auf die Natrium- und Wasserausscheidung bei Patienten mit Leberzirrhose und Aszites. Klin Wochenschr 67: 774-783
15. Brunkhorst R, Wrenger E, Malcharzik C, Brabant G, Koch KM (1993) Renal effects of atrial natriuretic peptide in cirrhotic rats with and without captopril pretreatment. Nephron 64: 275-281
16. Carcoana OV, Hines RL (1996) Is renal dose dopamine protective or therapeutic? Yes. Crit Care Clin 12: 677-685
17. Claria J, Jimenez W, Ros J, Asbert M, Castro A, Arroyo V, Rivera F, Rodes J (1992) Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 15: 343-349
18. Cosby RL, Yee B, Schrier RW (1989) New classification with prognostic value in cirrhotic patients. Miner Electrolyte Metab 15: 261-266
19. Davenport A, Aulton K, Payne RB, Will EJ (1990) Hyperlactatemia and increasing metabolic acidosis in hepatorenal failure treated by hemofiltration. Ren Fail 12: 99-101
20. Davenport A, Davison AM, Will EJ (1993) Membrane biocompatibility: effects on cardiovascular stability in patients on hemofiltration. Kidney Int Suppl 41: 5230-234
21. Davenport A, Will EJ, Davison AM (1993) Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl 41 : S245-251
22. Davison AM (1996) Hepatorenal failure. Nephrol Dial Transplant 11 Suppl 8: 24-31
23. Dudley FJ, Kanel GC, Wood LJ, Reynolds TB (1986) Hepatorenal syndrome without avid sodium retention. Hepatology 6: 248-251
24. Epstein M (1985) Derangements of renal water handling in liver disease. Gastroenterology 89: 1415-1425
25. Epstein M (1986) Renal prostaglandins and the control of renal function in liver disease. Am J Med 80: 46-55
26. Epstein M (1994) Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. J Am Soc Nephrol 4: 1735-1753
27. Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers TC, Abrams HL, Merrill JP (1970) Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 49: 175-185
28. Epstein M, Levinson R, Sancho J, Haber E, Re R (1977) Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res 41: 818-829
29. Epstein M, Weitzman RE, Preston S, DeNunzio AG (1984) Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis. Miner Electrolyte Metab 10: 155-165
30. Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM, Cohos MA, Rodriguez-Eire JL, Garcia-Plaza A, Leal J (1989) Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 97: 1304-1312
31. Flint A (1863) Clinical report on hydro-peritoneum, based on an analysis of forty-six cases. Am J Med Sci 45: 306-339
32. Forrest EH, Jones AL, Dillon JF, Walker J, Hayes PC (1995) The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. J Hepatol 23: 254-258
33. Gentilini P, Romanelli RG, La Villa G, Maggiore Q, Pesciullesi E, Cappelli G, Casini Raggi V, Foschi M, Marra F, Pinzani M (1993) Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology 104: 588-594
34. Gerbes AL (1997) Experimentelle Methoden in der Hepatologie. Richtlinien der Deutschen Arbeitsgemeinschaft zum Studium der Leber (GASL). Aszitestherapie bei Lebererkrankungen. Z Gastroenterol 35: 295-300
35. Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, Navasa M, Claria J, Rimola A, Arroyo V, et al. (1993) Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105: 229-236
36. Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB (1991) Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation 51: 428-430
37. Gottlieb LS, Trey C (1974) The effects of fluorinated anesthetics on the liver and kidneys. Annu Rev Med 25 :411-429
38. Groszmann RJ (1994) Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20: 1359-1363
39. Guarner C, Colina I, Guarner F, Corzo J, Prieto J, Vilardell F (1986) Renal prostaglandins in cirrhosis of the liver. Clin Sci 70: 477-484
40. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, Mourelle M, Moncada S (1993) Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 18: 1139-1143
41. Guevara M, Gines P, Fernandez-Esparrach G, Sort P, Salmeron JM. Jimenez W, Arroyo V, Rodes J (1998) Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27: 35-41
42. Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D (1992) Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology 15: 809-815
43. Henriksen JH, Ring-Larsen H (1994) Hepatorenal disorders: role of the sympathetic nervous system. Semin Liver Dis 14: 35-43
44. Hirokawa K, O'Shaughnessy K, Moore K, Ramrakha P, Wilkins MR (1994) Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cyclic AMP Br J Pharmacol 112: 396-402
45. Iwatsuki S, Popovtzer MM, Corman JL, Ishikawa M, Putnam CW, Katz FH, Starzl TE (1973) Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med 289: 1155-1159
46. Jalan R, Forrest EH, Redhead DN, Dillon JF, Hayes PC (1997) Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 40: 664-670
47. Jalan R, Redhead DN, Thomas HW, Henderson N, O'Rourke K, Dillon JF, Williams BC, Hayes PC (1996) Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 8: 1111-1116
48. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Klintmalm GB (1997) Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation 64: 1760-1765
49. Koppel MH, Coburn JW, Mims MM, Goldstein H, Boyle JD, Rubini ME (1969) Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease N Engl J Med 280: 1367-1371
50. Lafayette RA, Pare G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA (1997) Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 48: 159-164
51. Laffi G, Foschi M, Masini E, Simoni A, Mugnai L, la Villa G, Barletta G, Mannaioni PF, Gentilini P (1995) Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 22: 1666-1673
52. Lenz K, Hortnagl H, Druml W, Reither H, Schmid R, Schneeweiss B, Laggner A, Grimm G, Gerbes AL (1991) Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology 101 : 1060-1067
53. Levy M, Wexler MJ (1987) Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis. Am J Physiol 253: F664-671
54. Linas SL, Schaefer JW, Moore EE, Good JT, Jr, Giansiracusa R (1986) Peritoneovenous shunt in the management of the hepatorenal syndrome. Kidney Int 30: 736-740
55. Lohmeier TE, Cowley AW, Trippodo NC, Hall JE, Guyton AC (1977) Effects of endogenous angiotensin II on renal sodium excretion and renal hemodynamics. Am J Physiol 233: F388-F395
56. Lumsdcn AB, Henderson JM, Kutner MH (1988) Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232-236
57. Mandai AK, Lansing M, Fahmy A (1982) Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study. Am J Kidney Dis 2: 363-374
58. Marangoni R, Civardi F, Masi F, Savino R, Cimino R, Colombo R, Maltagliati L (1995) Lactate versus bicarbonate on-line hemofiltration: a comparative study. Artif Organs 19: 490-495
59. Martin PY, Schrier RW (1997) Pathogenesis of water and sodium retention in cirrhosis. Kidney Int Suppl 59: S43-49
60. Merli M, Salerno F, Riggio O, de Franchis R, Fiaccadori F, Meddi P, Primignani M, Pedretti G, Maggi A, Capocaccia L, Lovaria A, Ugolotti U, Salvatori F, Bezzi M, Rossi P (1998) Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 27: 48-53
61. Meyer M, Richter R, Brunkhorst R, Wrenger E, Schulz-Knappe P, Kist A, Mentz P, Brabant EG, Koch KM, Rechkemmer G, Forssmann WG (1996) Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects. Am J Physiol 271: F489-F497
62. Möller S, Sondergaard L, Mogelvang J, Henriksen O, Henriksen JH (1995) Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis. Hepatology 22: 472-478
63. Moore K (1997) The hepatorenal syndrome [editorial review]. Clin Sci (Colch) 92: 433-443
64. Moore K, Ward PS, Taylor GW, Williams R (1991) Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 100: 1069-1077
65. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K (1992) Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327: 1774-1778
66. Nicholls KM, Hapiro MD, Van Putten VJ, Kluge R, Chung HM, Bichet DG, Schrier RW (1985) Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion. Circ Res 56: 457-461
67. Niederberger M, Gines P, Tsai P, Martin PY, Morris K, Weigert A, McMurt ry I, Schrier RW (1995) Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. Hepatology 21: 1625-1631
68. Niederberger M, Martin PY, Gines P, Morris K, Tsai P, Xu DL, McMurtry I, Schrier RW (1995) Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 109: 1624-1630
69. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE (1995) The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites N Engl J Med 332: 1192-1197
70. Olbricht CJ, Huxmann-Nägeli D, Bischoff H (1990) Bikarbonat- statt laktatgepufferter Substitutionslösung zur kontinuierlichen Hamofiltration im Intensivbereich. Anästh Intensivther Notfallmed 25: 164-167
71. Pak JM, Lee SS (1994) Glucagon in portal hypertension. J Hepatol 20: 825-832
72. Papadakis MA, Arieff AI (1987) Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 82: 945-952
73. Persson PB, Ehmke H, Nafz B, Kirchheim HR (1990) Sympathetic modulation of renal autoregulation by carotid occlusion in conscious dogs. Am J Physiol 258:F364-370
74. Pizcueta P, Pique JM, Fernandez M, Bosch J, Rodes J, Whittle BJ, Moncada S (1992) Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 103: 1909-1915
75. Platt JF, Ellis JH, Rubin JM. Merion RM, Lucey MR (1994) Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease. Hepatology 20: 362-369
76. Plotz PH, Kimberly RP (1981) Acute effects of aspirin and acetaminophen on renal function. Arch Intern Med 141: 343-348
77. Rees CJ, Rose JD Record CO, Day CP, Bassendine MF, James OF, Hudson M (1997) Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites. Eur J Gastroenterol Heptol 9: 969-973
78. Ros J, Jimenez W, Lamas S, Claria J, Arroyo V, Rivera F, Rodoes J (1995) Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 21: 554-560
79. . Salo J, Fernandez-Esparrach G, Gines P, Gines A, Guevara M, Sort P, Jimenez W, Arroyo V, Rivera F, Rodes J (1997) Urinary endothelin-like immunoreactivity in patients with cirrhosis. J Hepatol 27: 810-816
80. Salo J, Jimenez W, Kuhn M, Gines A, Gines P, Fernandez-Esparrach G, Angeli P, Claria J, Bataller R, Arroyo V, Forssmann WG, Rodes J (1996) Urinary excretion of urodilatin in patients with cirrhosis. Hepatology 24: 1428-1432
81. Schrier RW (1988) Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. N Engl J Med 319: 1127-1134
82. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8: 1151-1157
83. Schrier RW, Howard RL (1991) Unifying hypothesis of sodium and water regulation in health and disease. Hypertension 18: III164-168
84. Solis-Herruzo JA, Duran A, Favela V, Castellano G, Madrid JL, Munoz-Yague MT, Morillas JD, Estenoz J (1987) Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol 5: 167-173
85. Stark ME, Szurszewski JH (1992) Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103: 1928-1949
86. Sussman NL, Gislason GT, Kelly JH (1994) Extracorporeal liver support. Application to fulminant hepatic failure. J Clin Gastroenterol 18 320-324
87. Sussman NL, Lake JR (1996) Treatment of hepatic failure - 1996: current concepts and progress toward liver dialysis. Am J Kidney Dis 27: 605-621
88. . Uemura K, Oguchi H, Kiyosawa K, Furuta S (1989) Plasma human atrial natriureitic peptide levels in patients with liver cirrhosis. J Gastroenterol Hepatol 4: 167-174
89. Uemura M, Buchholz U, Kojima H, Keppler A, Hafkemeyer P, Fukui H, Tsujn T, Keppler D (1994) Cysteinyl leukotrienes in the urine of patients with liver diseases. Hepatology 20: 804-812
90. Van Roey G, Moore K (1996) The hepatorenal syndrome. Pediatr Nephrol 10: 100-107
91. Villeneuve JP, Dagenais M, Huet PM, Roy A, Lapointe R, Marleau D (1996) The hepatic microcirculation in the isolated perfused human liver. Hepatology 23: 24-31
92. Weigert AL, Martin PY, Niederberger M, Higa Em, McMurtry IF, Gines P, Schrier RW (1995) Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 22: 1856-1862
93. Wilkinson SP, Williams R (1980) Renin-angiotensin-aldosterone system in cirrhosis. Gut 21: 545-554
94. Zarich S, Fang LS, Diamond JR (1985) Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med 145: 108-112
95. Zipser RD (1986) Role of renal prostaglandins and the effects of non-steroidal anti-inflammatory drugs in patients with liver disease. Am J Med 81: 95-103
96. Zipser RD, Kronborg I, Rector W, Reynolds T, Daskalopoulos G (1984) Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. Gastroenterology 87: 1228-1232